United States Renal Data System (2023) 2023 Annual Data Report: Ch 1, Incidence, Prevalence, Patient Characteristics, and Treatment Modalities. https://usrds-adr.niddk.nih.gov/2023/end-stage-renal-disease/1-incidence-prevalence-patient-characteristics-and-treatment-modalities. Accessed 15 March 2024

European Renal Association (2022) ERA Registry Annual Report 2021. https://www.era-online.org/wp-content/uploads/2023/12/ERA-Registry-Annual-Report-2021_231206.pdf. Accessed 15 March 2024

Cornec-Le Gall E, Alam A, Perrone RD (2019) Autosomal dominant polycystic kidney disease. Lancet 393(10174):919–935. https://doi.org/10.1016/S0140-6736(18)32782-X

Article  PubMed  Google Scholar 

Gabow PA (1993) Autosomal dominant polycystic kidney disease. N Engl J Med 329(5):332–342. https://doi.org/10.1056/NEJM199307293290508

Article  CAS  PubMed  Google Scholar 

Luciano RL, Dahl NK (2014) Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management. Nephrol Dial Transplant 29(2):247–254. https://doi.org/10.1093/ndt/gft437

Article  PubMed  Google Scholar 

Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E et al (2012) Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 367(25):2407–2418. https://doi.org/10.1056/NEJMoa1205511

Article  CAS  PubMed  PubMed Central  Google Scholar 

Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G et al (2017) Tolvaptan in later-stage autosomal dominant polycystic kidney disease. N Engl J Med 377(20):1930–1942. https://doi.org/10.1056/NEJMoa1710030

Article  CAS  PubMed  Google Scholar 

Chedid M, Kaidbay HD, Wigerinck S, Mkhaimer Y, Smith B, Zubidat D et al (2022) Cardiovascular outcomes in kidney transplant recipients with ADPKD. Kidney Int Rep 7(9):1991–2005. https://doi.org/10.1016/j.ekir.2022.06.006

Article  PubMed  PubMed Central  Google Scholar 

Perrone RD, Ruthazer R, Terrin NC (2001) Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality. Am J Kidney Dis 38(4):777–784. https://doi.org/10.1053/ajkd.2001.27720

Article  CAS  PubMed  Google Scholar 

Bhutani G, Astor BC, Mandelbrot DA, Mankowsi-Gettle L, Ziemlewicz T, Wells SA et al (2020) Long-term outcomes and prognostic factors in kidney transplant recipients with polycystic kidney disease. Kidney360 2(2):312–324. https://doi.org/10.34067/KID.0001182019

Article  PubMed  PubMed Central  Google Scholar 

Florijn KW, Chang PC, Woude FJ, Bockel JH, Saase JL (1994) Long-term cardiovascular morbidity and mortality in autosomal dominant polycystic kidney disease patients after renal transplantation. Transplantation 57(1):73–81. https://doi.org/10.1097/00007890-199401000-00014

Article  CAS  PubMed  Google Scholar 

Illesy L, Kovács DÁ, Szabó RP, Asztalos L, Nemes B (2017) Autosomal dominant polycystic kidney disease transplant recipients after kidney transplantation: a single-center experience. Transplant Proc 49(7):1522–1525. https://doi.org/10.1016/j.transproceed.2017.06.014

Article  CAS  PubMed  Google Scholar 

World Medical Association (2013) Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310(20):2191–2194. https://doi.org/10.1001/jama.2013.281053

Article  CAS  Google Scholar 

International Summit on Transplant Tourism and Organ Trafficking (2008) The Declaration of Istanbul on organ trafficking and transplant tourism. Kidney Int 74(7):854–859. https://doi.org/10.1038/ki.2008.388

Article  Google Scholar 

Sharif A, Hecking M, Vries APJ, Porrini E, Hornum M, Rasoul-Rockenschaub S et al (2014) Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transplant 14(9):1992–2000. https://doi.org/10.1111/ajt.12850

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsung-Yin T, Cheng-Hsu C, Ming-Ju W, Shang-Feng T (2022) Outcomes of kidney transplantation in patients with autosomal dominant polycystic kidney disease: our experience based on 35-years follow-up. Diagnostics 12(5):1174. https://doi.org/10.3390/diagnostics12051174

Article  Google Scholar 

Culliford A, Phagura N, Sharif A (2020) Autosomal dominant polycystic kidney disease is a risk factor for posttransplantation diabetes mellitus: an updated systematic review and meta-analysis. Transplant Direct 6(5):e553. https://doi.org/10.1097/TXD.0000000000000989

Article  PubMed  PubMed Central  Google Scholar 

Piergiorgio M, Carlo MA, Emanuele M, Mariano F, Roberta C (2016) ADPKD: clinical issues before and after renal transplantation. J Nephrol 29:755–763. https://doi.org/10.1007/s40620-016-0349-7

Article  Google Scholar 

Ruderman I, Masterson R, Tates C, Gorelik A, Cohney SJ, Walker RG (2012) New onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: a retrospective cohort study. Nephrology (Carlton) 17(1):89–96. https://doi.org/10.1111/j.1440-1797.2011.01507.x

Article  CAS  PubMed  Google Scholar 

Vareesangthip K, Tong P, Wilkinson R, Thomas TH (1997) Insulin resistance in adult polycystic kidney disease. Kidney Int 52(2):503–508. https://doi.org/10.1038/ki.1997.360

Article  CAS  PubMed  Google Scholar 

Rowe I, Chiaravalli M, Mannella V, Ulisse V, Quilici G, Pema M et al (2013) Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat Med 19(4):488–493. https://doi.org/10.1038/nm.3092

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caillard S, Eprinchard L, Perrin P, Braun L, Heibel F, Moreau F et al (2011) Incidence and risk factors of glucose metabolism disorders in kidney transplant recipients: role of systematic screening by oral glucose tolerance test. Transplantation 91(7):757–764. https://doi.org/10.1097/TP.0b013e31820f0877

Article  CAS  PubMed  Google Scholar 

de Mattos AM, Olyaei A, Prather JC, Golconda MS, Barry JM, Norman DJ (2005) Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation. Kidney Int 67(2):714–720. https://doi.org/10.1111/j.1523-1755.2005.67132.x

Article  PubMed  Google Scholar 

Pietrzak-Nowacka M, Safranow K, Rózański J, Debska-Slizień A, Domański L, Dziewanowski K et al (2008) Autosomal dominant polycystic kidney disease is not a risk factor for post-transplant diabetes mellitus. matched-pair design multicenter study. Arch Med Res 39(3):312–9. https://doi.org/10.1016/j.arcmed.2007.10.003

Article  CAS  PubMed  Google Scholar 

Robin KA, Jennifer DM, Kyle RJ, Robert AM, Allan BM, Edward SK et al (2021) Quantifying infection risks in incompatible living donor kidney transplant recipients. Am J Transplant 21(4):1564–1575. https://doi.org/10.1111/ajt.16316

Article  CAS  Google Scholar 

Thomas S, Maik S, Petra R (2015) ABO desensitization affects cellular immunity and infection control after renal transplantation. Transpl Int 28(10):1179–1194. https://doi.org/10.1111/tri.12616

Article  CAS  Google Scholar 

Zhong-Yu K, Chun L, Wei L, Daihong L (2023) Association between blood transfusion after kidney transplantation and risk for the development of de novo HLA donor-specific antibodies and poor clinical outcomes: a single-center retrospective study. Transpl Immunol 81:101930. https://doi.org/10.1016/j.trim.2023.101930

Article  CAS  Google Scholar 

Matthew JE, Kimberly PB, Carl EH, Georg D, Paul B, Scott AK et al (2017) Racial differences in incident de novo donor-specific anti-HLA antibody among primary renal allograft recipients: results from a single center cohort study. Transpl Int 30(6):566–578. https://doi.org/10.1111/tri.12937

Article  CAS  Google Scholar 

Marten AL, Niek FC, Alix G, Ruud GL, Sander VA, Anna ML, Ron TG, Joost PHD (2016) Management of renal cyst infection in patients with autosomal dominant polycystic kidney disease: a systematic review. Nephrol Dial Transplant 32(1):144–150. https://doi.org/10.1093/ndt/gfv452

Article  CAS  Google Scholar 

Sidar C, Lasin O, Mustafa G, Ahmet UT, Mehmet K (2024) Native nephrectomy in polycystic kidney disease patients on transplant lists: how and when? J Nephrol. https://doi.org/10.1007/s40620-024-01899-7

Article  Google Scholar